Marketer Tips reposted this
In 2023, everyone wanted Ozempic. The problem? It cost $1,000 a month and was constantly out of stock! Hims saw the gap and launched compounded semaglutide (the same active ingredient) for a fraction of the price Over $225 million in revenue in one year! This is the strategy nobody wants to admit works: copy what's proven, make it accessible. Hims didn't invent GLP-1. They didn't do the research. They didn't take the risk. They waited until demand was obvious, then offered a cheaper, easier version. And it worked because: - The market was already educated (everyone knew what semaglutide was) - The pain was real (people couldn't afford or access the name brand) - The trust was built (Hims already served 2 million subscribers) This is the "fast follower" strategy, and it's wildly underrated. You don't need to be first. You need to be better, cheaper, or easier. Hims was all three. For your brand: Stop trying to invent the category. Watch what's working, then ask: "How do we make this more accessible?" The innovator takes the risk. The fast follower takes the market.